Navigation Links
Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Actos Bladder Cancer Litigation
Date:7/21/2013

New York, New York (PRWEB) July 21, 2013

Actos lawsuit claims involving allegations that the drug caused users to develop bladder cancer continue to move forward in a multidistrict litigation now underway in U.S District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to court documents, the Actos bladder cancer litigation’s next Status Conference has been scheduled for Thursday, July 25th. An update issued by the U.S. Judicial Panel on Multidistrict Litigation on July 10th indicated that more than 2,400 Actos lawsuits are now pending in the consolidated proceeding. (In re: Actos Product Liability Litigation, MDL No. 2299)

“We continue to hear from individuals seeking to file Actos lawsuits that allege the drug caused their bladder cancer. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to patients who developed the disease after using the medication for an extended period of time

Actos Bladder Cancer Lawsuits
Actos lawsuits pending in the Western District of Louisiana accuse Takeda Pharmaceuticals of concealing knowledge that use of the type 2 diabetes treatment was associated with an increased risk of bladder cancer, and failing to provide adequate warnings to patients and doctors regarding this risk. According to court documents, the first trial in the federal Actos litigation is scheduled to begin on January 27, 2014.

In April, the nation’s first trial involving Actos bladder cancer allegations ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking Actos for four yea
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 Horizon Blue Cross Blue ... its efforts to combat health insurance fraud resulted in ... of monies recovered and losses avoided -- in 2014. ... Horizon BCBSNJ created its fraud fighting, Special Investigations Unit ... efforts have saved members $261 million. , “Our ...
(Date:3/31/2015)... Altima Technologies, Inc., the maker ... documenting and diagramming data center assets and audio-video ... Manufacturer / Device Model, Dell N3000 Series, Dell ... Dell PowerEdge r630, Cisco Catalyst 3850 Series, HP ... 100K, VMAX 200K, VMAX 400K , “With NetZoom ...
(Date:3/31/2015)... The Oliver Law Group, who ... notes that filings for testosterone lawsuits that allege ... complications associated with testosterone therapy products such as ... steady pace. The website for the U.S. District ... lawsuits have been centralized, shows 1,291 testosterone lawsuits ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 When SIGVARIS launched ... company’s most successful product launch to date. Women immediately fell ... is giving women another reason to love EVERSHEER with the ... for spring. , Lavender mist pairs perfectly with a ... neutral outfits. For women looking to add a hint of ...
(Date:3/31/2015)... 2015 India Network Foundation , ... a travel advisory to all USA bound international travelers ... United States are higher than many other countries and ... For example, a coronary artery bypass graft costs ... about $34,358 . Visitors are advised to get ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 3Health News:Put Spring in Your Step with SIGVARIS’ Top Selling Sheer Hosiery Compression Therapy Brand 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3
... February 16, 2011 An article published in a forthcoming ... of the first to provide evidence of the effectiveness ... suffering from posttraumatic stress disorder (PTSD). The study shows ... in PTSD symptoms after an average of seven treatment ...
... Sciences, National Academy of Engineering, Institute of Medicine, and National ... annual meeting of the American Association for the Advancement of ... Washington, D.C. Tribute to Stephen H. ... East (Renaissance Downtown), Stephen Schneider, a renowned climate scientist at ...
... 16, 2011 − One of the tough challenges a parent ... parent the surviving children, and the task begins immediately, according ... moment their child dies, parents are faced with the two ... a child and the ongoing, daily demands from their surviving ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... when they,re first tested may not need to be screened ... new study suggests. Dutch researchers presenting the findings ... few men with a PSA below 3.0 ng/ml were likely ...
... newly diagnosed with Alzheimer,s disease or other dementias, and ... how to plan for the patient,s progressive loss of ... by a physician at the San Francisco VA Medical ... "When a patient is diagnosed with Alzheimer,s disease or ...
... -- Psychotherapy triggers changes in the brains of people ... Medication and psychotherapy are used to treat people with ... overwhelming fear of interacting with others and of being ... the neurological effects of psychotherapy (talk therapy) than on ...
Cached Medicine News:Health News:Innovative virtual reality exposure therapy shows promise for returning troops 2Health News:Media advisory -- events at AAAS 2Health News:Media advisory -- events at AAAS 3Health News:Media advisory -- events at AAAS 4Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 3Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:'Talk Therapy' Can Alter Brain Activity, Research Shows 2
(Date:3/31/2015)... , March 31, 2015  CVS Health ... entered into new clinical affiliations with Rush University ... and Tucson Medical Center in ... organization, Arizona Connected Care. These affiliations will help ... for patients. Through these clinical affiliations, CVS Health ...
(Date:3/31/2015)... 2015 Biorasi , a full-service ... partnership with Medidata , the leading global ... life sciences. Offering therapeutic expertise in a number ... electronic data capture (EDC), management and reporting system, ... IV global clinical trial business. ...
(Date:3/31/2015)... -- The growing threat posed by multi-drug resistant gram-negative ... to the development of antibacterial drugs worldwide. Upcoming ... incentives for new drug identification will create attractive ... http://photos.prnewswire.com/prnh/20150331/195565LOGO New analysis from ... of the Antibacterial Drugs Market, finds that nearly ...
Breaking Medicine Technology:CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4Development and Commercialization of Antibacterial Drugs to Speed Up 2Development and Commercialization of Antibacterial Drugs to Speed Up 3
... The Barbara Ann Karmanos Cancer Institute announced today that its spin-off ... capital to start the commercialization process of SoftVue, an alternative to mammography. ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) , ... SoftVue is a tomographic ultrasound imaging and ...
... 24 Genzyme Corp. has signed a consent decree agreeing to correct manufacturing ... to the federal government $175 million in unlawful profits from the sale ... announced today. , , , ... , , ...
Cached Medicine Technology:Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 2Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 3Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 4Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 5Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: